CFO
Jagsonpal Pharmaceuticals Limited
Equibles does not estimate personal net worth.
Nirav Vora is recorded as CFO at Jagsonpal Pharmaceuticals Limited. Nirav Vora has spoken on 2 earnings calls across 1 company, most recently for Jagsonpal Pharmaceuticals Limited on October 29, 2026. Jagsonpal Pharmaceuticals Limited is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector.
“10% people, marketing, and medical inputs are consolidated with a margin stood at 19.3%. As the bottom line, stand-down tax stood at 13 crore, while consolidated tax was 12 crore, with a margin of 15.5% and 12.8% respectively.”
“We have continued our commitment to enhancing share-to-value through the successful completion of our share by bank. Revenue from operations increased close to 9% year-on-year to 82 crores, while gross profit grew over 10% to 54 crores, with gross margins improving to 65% less.”
Jagsonpal Pharmaceuticals Limited
CFO
Transcript header (unverified)
Jagsonpal Pharmaceuticals Limited
Drug Manufacturers - Specialty & Generic · Healthcare
CFO
Earnings Call
Jagsonpal Pharmaceuticals Limited
Earnings Call
Jagsonpal Pharmaceuticals Limited
